InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
3
T+90 hit rate
67%
T+90 mean return
+31.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Arkowitz David, Chief Financial Officer. Director active across 4 companies, notably Flexion Therapeutics Inc. Cumulatively, 10 disclosures have been logged. Split: 1 buy · 3 sells. Total volume traded: €80k. Activity tracked since 10 May 2021. The latest transaction was filed on 10 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
18,382 shares@ US$2.72100.0% of flowCommon StockSEC:0001104659-25-003061:0
Ideal exit: 7 Oct 2025 (T+270)
10,625 sharesCommon StockSEC:0000950170-24-016687:0
13,209 shares0Common StockSEC:0000899243-23-020077:0
4,066 shares@ US$1.352.6% of flowCommon StockSEC:0000899243-23-020077:1
42,500 shares0Common stockSEC:0000899243-23-011944:0
8,386 shares@ US$7.12100.0% of flowCommon StockSEC:0000899243-23-007654:0
5,000 shares0Common stockSEC:0000899243-22-034577:0
63,492 shares@ US$3.1597.4% of flowCOMMON STOCKSEC:0000899243-22-025516:0
2,229 shares@ US$7.2350.0% of flowCommon StockSEC:0001209191-21-032103:0
2,229 shares@ US$7.2350.0% of flowCommon StockSEC:0001209191-21-032103
10 of 10 declarations
About Arkowitz David
David Arkowitz is the Chief Financial Officer of Flexion Therapeutics Inc. He oversees the financial management of the company, including planning and financial reporting.
